Kailera Therapeutics, Inc. (KLRA)

Healthcare · Biotechnology · NASDAQ

Kailera Therapeutics, Inc. (KLRA) is a Healthcare company in the Biotechnology industry. It has a market capitalization of $2.42B and a free-cash-flow yield of -5.6%.

Market cap	$2.42B
Trailing P/E	—
FCF yield	-5.6%
Revenue growth (YoY)	—
EPS growth (YoY)	—
FCF/share growth (YoY)	—
Exchange	NASDAQ
Sector	Healthcare
Industry	Biotechnology

Explore live KLRA data on Nama Insights →